Data protection Impressum

Medtech

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (March 2024)

26 March 2024

This funding is poised to extend the company's financial runway into mid-2025, as it gears up for the approval and launch of pioneering products designed to enhance the lives of individuals with spinal cord injuries (SCI).

ONWARD Medical secures EUR 20 million to expand its spinal cord injury therapies

26 March 2024

This financial infusion is set to bolster the clinical advancement of Volumina Medical’s injectable dermal filler, Adipearl.

Volumina Medical raises USD 21 million to advance regenerative medicine

25 March 2024

This funding follows closely on the heels of the completion of enrollment of Spineart’s BAGUERA® C Intervertebral Disc (IDE) studies, which aim to push the boundaries of spinal surgery through extensive research and development efforts.

Spineart raises CHF 20 million to push the boundaries of spinal surgery

20 March 2024

PeriVision’s innovative platform melds Virtual Reality (VR) and Artificial Intelligence (AI) to modernize and improve eye testing for ophthalmologists and optometrists.

PeriVision registers VR- & AI-based eye testing platform VisionOne with US FDA

19 March 2024

Argá Medtech's technology assesses the safety and effectiveness of coherent sine wave electroporation in patients with atrial fibrillation.

Argá Medtech secures EUR 54 million towards its atrial fibrillation treatment

6 March 2024

Artiria Medical’s deflectable guidewire provides an actively deformable tip and enhanced dynamic in-situ control resulting in seamless access to neurovascular targets.

Artiria Medical secures significant funding to advance stroke treatment

6 March 2024

This investment propels Aktiia's mission to address the global challenge of hypertension, which affects over 1.4 billion individuals worldwide and is responsible for more than 18 million deaths annually.

Aktiia secures CHF 27 million to combat global hypertension crisis

4 March 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (February 2024)

27 February 2024

CSEM and ClexBio, a Nordic startup specializing in regenerative medicine, has developed a novel bioreactor capable of cultivating human veins in the laboratory.

CSEM and ClexBio unveil groundbreaking bioreactor to advance cardiovascular treatment

26 February 2024

1 … 7 8 9 10 11 12 13 14 15